BeStock  
Stocks › Biotechnology › CORT

Corcept Therapeutics CORT

US equityMarket cap rank #772Biotechnology
$114.14 −$1.09 (-0.95%)
Market open · Oct 1, 1:20 pm ET · After hours $115.23 0.00%
Open$114.29
Prev close$115.23
Day range$111.94 – $115.98
Volume342.9K
Market cap$12.34B
P/E (TTM)253.6
Dividend yield–

CORT Stock News

Headlines matching Corcept Therapeutics or the CORT ticker, most recent first.

  • H.C. Wainwright Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $165Market news · 19 Sep 2026
  • Form 144 | Corcept Therapeutics(CORT.US) Director Proposes to Sell 3.34 Million in Common StocksMarket news · 15 Sep 2026
  • Corcept Therapeutics(CORT.US) Officer Sells US$3.89 Million in Common StockMarket news · 28 Aug 2026
  • Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $165Market news · 21 Aug 2026
  • Corcept Therapeutics(CORT.US) Director Sells US$12.25 Million in Common StockMarket news · 21 Aug 2026
  • Truist Financial Initiates Corcept Therapeutics(CORT.US) With Buy Rating, Announces Target Price $164Market news · 18 Aug 2026
  • CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $161Market news · 13 Aug 2026
  • CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $135Market news · 9 Jul 2026
  • H.C. Wainwright Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Raises Target Price to $165Market news · 30 Jul 2026
  • Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Raises Target Price to $165Market news · 30 Jul 2026
  • Wolfe Research Maintains Corcept Therapeutics(CORT.US) With Sell Rating, Maintains Target Price $50Market news · 30 Jul 2026
  • CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Raises Target Price to $161Market news · 29 Jul 2026
  • Wolfe Research Downgrades Corcept Therapeutics(CORT.US) to Sell Rating, Announces Target Price $50Market news · 27 Jul 2026
  • H.C. Wainwright Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $95Market news · 2 Jun 2026
  • Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $88Market news · 1 Jun 2026

Discussion

No comments yet — be the first to weigh in on CORT.

Leave a comment

Scroll to Top